Company / Revenue per Share
Arcutis Biotherapeutics, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.19
FY2025
5-year range
$0.07 / $3.19
FY2022-FY2025
Trend
+57.1%
vs FY2024
Sector context
#75 of 154
Health Care
What the data says
At $3.19, Arcutis Biotherapeutics, Inc.'s revenue per share ranks #75 of 154 in the Health Care sector. Revenue per Share has increased for 3 consecutive years, from $0.07 in FY2022 to $3.19 in FY2025.
Based on SEC 10-K filings.
3.19 in FY2025 with a 3-year CAGR of +262.5%.
Improved from $0.86 to $3.19 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +262.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#75 of 154 in Health CareTop 49% of 154This company $3.19 Sector average $10.35
▼
-69.2% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 57.1% year-over-year.
- Ranks #75 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.19 | +57.1% |
| FY2024 | $2.03 | +136.1% |
| FY2023 | $0.86 | +1184.1% |
| FY2022 | $0.07 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026